---

---

tags : Positive    crawled date : 2021 - 11 - 12   

save search

---

Oncorus Reports Initial Safety, Tolerability, Immune Activation and Positive Clinical Response Data from its Ongoing Phase 1 Clinical Study of ONCR-177, its Lead Viral Immunotherapy Candidate, at SITC 2021
Published: 2021-11-12 (Crawled : 23:00) - biospace.com/
ONCR | $0.126 -75.95% 140K |

Health Technology

| -98.83% | O: -35.41% H: 1.67% C: -15.76%
immunotherapy ongoing phase 1 positive therapy

---

Second Genome Presents Preclinical Data at SITC 2021 Demonstrating that a CXCR3-Positive Allosteric Modulator, SG-3-00802, Targets a Key Mechanism Required for Efficacious Immunotherapy
Published: 2021-11-12 (Crawled : 23:00) - biospace.com/
GILD | $67.03 0.12% 0.12% 5.2M |

Health Technology

| -0.71% | O: 0.27% H: 0.0% C: 0.0%
preclinical immunotherapy positive therapy pre-clinical

---

Aravive Announces Positive Preliminary Data from Phase 1b Trial Evaluating Batiraxcept (AVB-500) in Combination with Cabozantinib for Treatment of Clear Cell Renal Cell Carcinoma
Published: 2021-11-12 (Crawled : 22:00) - biospace.com/
ARAV | $0.0401 4.74% 4M |

Health Technology

| -98.78% | O: 4.47% H: 0.0% C: 0.0%
treatment phase 1 renal positive phase 1b trial phase 2b cell carcinoma

---

REGENXBIO Presents Additional Positive Interim Data from Trials of RGX-314 in Wet AMD and Diabetic Retinopathy Using Suprachoroidal Delivery at AAO 2021
Published: 2021-11-12 (Crawled : 22:00) - biospace.com/
RGNX | $15.885 1.57% 1.54% 360K |

Health Technology

| -58.35% | O: -0.53% H: 0.0% C: 0.0%
CLSD | News P | $1.36 -3.55% -3.68% 230K |

Health Technology

| -71.17% | O: 0.41% H: 1.43% C: -0.41%
positive trials liver trial diabetic diabetes

---

Open Positions – Analytical Chemistry
Published: 2021-11-12 (Crawled : 18:00) - otonomy.com
OTIC | $0.077 |

Health Technology

| -96.31% | O: 2.38% H: 0.0% C: 0.0%
positive

---

Positive Resmetirom Data from Completed Open-Label Portion of Phase 3 MAESTRO-NAFLD-1 Clinical Study Presented at American Association for the Study of Liver Diseases (AASLD) The Liver Meeting® Digital Experience 2021
Published: 2021-11-12 (Crawled : 17:00) - biospace.com/
MDGL | $218.17 2.19% 2.15% 410K |

Health Technology

| 132.31% | O: 0.09% H: 0.0% C: 0.0%
disease liver disease positive phase 3 liver

---

Sorrento Announces Publication of Significant Positive Pivotal Trial Results of Abivertinib for the Treatment of Non-Small Cell Lung Cancer (NSCLC) in the Peer-Reviewed Journal Clinical Cancer Research
Published: 2021-11-12 (Crawled : 15:00) - globenewswire.com
SRNE | $0.015 -8.85% 140K |

Health Technology

| -99.84% | O: 1.34% H: 0.0% C: 0.0%
treatment lung cancer positive results cancer research trial trial results

---

Positive Recommendation for Use of TAVNEOS™ (avacopan) in ANCA Vasculitis Adopted by European Medicines Agency (EMA) Committee for Medicinal Products for Human Use (CHMP)
Published: 2021-11-12 (Crawled : 14:00) - globenewswire.com
CCXI | News | $51.99 -0.04% |

Health Technology

| 37.32% | O: 1.56% H: 0.0% C: 0.0%
ema europe anca vasculitis positive avacopan chmp

---

Vertex Receives CHMP Positive Opinion for KAFTRIO® (ivacaftor/tezacaftor/elexacaftor) in Combination With Ivacaftor in Children With Cystic Fibrosis Ages 6 Through 11
Published: 2021-11-12 (Crawled : 13:00) - biospace.com/
VRTX | $404.93 1.25% 1.43% 1.1M |

Health Technology

| 111.46% | O: -0.54% H: 0.0% C: 0.0%
fibrosis positive chmp children cystic fibrosis

---

LUMYKRAS® (sotorasib) Receives Positive Opinion From EMA CHMP For Patients With KRAS G12C-Mutated Advanced Non-Small Cell Lung Cancer
Published: 2021-11-12 (Crawled : 13:00) - biospace.com/
BGNE | $139.22 6.32% 5.95% 200K |

Health Technology

| -64.09% | O: 1.02% H: 0.0% C: 0.0%
AMGN | News | $273.69 0.66% 0.65% 2.5M |

Health Technology

| 27.23% | O: -0.92% H: 0.0% C: 0.0%
ema lung cancer positive cancer chmp

---

Ascendis Pharma A/S Receives Positive CHMP Opinion for TransCon™ hGH for Patients with Pediatric Growth Hormone Deficiency
Published: 2021-11-12 (Crawled : 13:00) - globenewswire.com
ASND | $145.17 2.16% 2.11% 220K |

Health Technology

| -7.66% | O: 0.53% H: 0.0% C: 0.0%
growth hormone positive chmp growth hormone

---

Phio Pharmaceuticals Presents Positive New Data On Systemic Immune Response After Local PH-762 Therapy at the SITC 36th Annual Meeting
Published: 2021-11-12 (Crawled : 12:00) - prnewswire.com
PHIO | News | $0.6709 -19.16% -23.7% 640K |

Health Technology

| -48.45% | O: -4.35% H: 0.0% C: 0.0%
positive therapy

---

Gainers vs Losers

78%

22%

Top 10 Gainers

MTTR | News 4 | $4.6 164.37% 62.17% 28M |

AGBA | $2.94 135.2% 57.48% 66M |

Finance

EDBL | News | $6.46 71.81% 41.8% 2M |

MTC | $2.25 44.23% 30.67% 6M |

Technology Services

OPRT | News | $3.175 41.11% 29.13% 12M |

Finance

SHIM | $3.05 35.56% 26.23% 1.1M |

HKIT | $1.345 31.86% 24.16% 390K |

Technology Services

ABVC | $1.36 30.77% 23.53% 7.4M |

Wholesale Trade

OST | $0.512 28.0% 21.88% 290K |

POET | $1.59 27.2% 21.38% 4.2M |

Manufacturing

---

Your saved searches

---